Christoph Eisenbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christoph Eisenbach has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Wolfgang Stremmel
Medical Center Baden-Baden, D-76530 Baden-Baden, Germany
16 shared publications - Stefan Mauss
Center for HIV and Hepatogastroenterology Düsseldorf Germany
8 shared publications Gero Moog
7 shared publications- Peter Buggisch
Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany
7 shared publications - Renate Heyne
Liver and Study Center Checkpoint, 10969 Berlin, Germany
7 shared publications Ulrich Alshuth
7 shared publications
Latest Publications
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E314-E315
Microscopic (collagenous) colitis in a patient with a heart transplant
A 62-year old female patient presented with symptoms of watery diarrhea, abdominal discomfort, and weight loss persisting for several weeks. The patient had undergone a heart transplant procedure 10 years earlier because of ischemic cardiomyopathy. Immunosuppression consisted of cyclosporin A and mycophenolate mofetil (CellCept; Genentech, South San Francisco, California, USA). Steroids had been stopped 3 months before. The clinical examination findings were normal. Laboratory work-up showed kidney failure (serum creatinine, 2.54 mg/dL) and mild hyponatremia. The C-reactive protein level and leukocyte count were normal, whereas the procalcitonin level (0.09 ng/mL; normal < 0.05), ferritin level (137 µg/L; normal 20 – 120), and blood sedimentation rate (42 mm/h) were slightly elevated. Results of testing for immunoglobulin A (IgA) anti-tissue transglutaminase antibodies and IgA anti-gliadin antibodies were negative. Results of stool analysis, sonography, computed tomography, and esophagogastroduodenoscopy with Helicobacter pylori testing were normal. A biopsy specimen from the descending duodenum showed no signs of inflammation, celiac disease, Whipple disease, or lambliasis. A colonoscopy revealed mucosal edema and a diminished vascular pattern [1] ([Fig. 1]). Biopsy specimens obtained from the sigmoid colon showed features of collagenous colitis ([Fig. 2]), which led to the diagnosis of microscopic (collagenous) colitis. The patient was treated with budenoside [2], and her symptoms rapidly decreased. After 4 weeks, the microscopic findings were normal. Diarrhea is common in patients with solid organ transplants and is usually attributed to infection or side effects of medication. The suspicion of microscopic colitis in a patient with a transplant is counterintuitive because immunosuppressants are effective in the treatment of microscopic colitis. Only a few cases have been reported, none of them in patients with heart transplants [3]. We cannot completely rule out gastrointestinal infection, as has been reported for lymphocytic colitis [4]. However, infection-associated collagenous colitis is unlikely. Of the possibly causative drugs, the patient´s medications included a proton pump inhibitor and a statin, but no nonsteroidal anti-inflammatory drug [5]. The patient’s medication was not changed during follow-up. To the best of our knowledge, this is the first report of microscopic colitis occurring in a patient with a heart transplant. Microscopic colitis should be considered when diarrhea of unknown etiology occurs in a patient with a solid organ transplant. Endoscopy_UCTN_Code_CCL_1AD_2AD
- 20 January 2015
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 47 (S 01) , E314-E315
Microscopic (collagenous) colitis in a patient with a heart transplant
A 62-year old female patient presented with symptoms of watery diarrhea, abdominal discomfort, and weight loss persisting for several weeks. The patient had undergone a heart transplant procedure 10 years earlier because of ischemic cardiomyopathy. Immunosuppression consisted of cyclosporin A and mycophenolate mofetil (CellCept; Genentech, South San Francisco, California, USA). Steroids had been stopped 3 months before. The clinical examination findings were normal. Laboratory work-up showed kidney failure (serum creatinine, 2.54 mg/dL) and mild hyponatremia. The C-reactive protein level and leukocyte count were normal, whereas the procalcitonin level (0.09 ng/mL; normal < 0.05), ferritin level (137 µg/L; normal 20 – 120), and blood sedimentation rate (42 mm/h) were slightly elevated. Results of testing for immunoglobulin A (IgA) anti-tissue transglutaminase antibodies and IgA anti-gliadin antibodies were negative. Results of stool analysis, sonography, computed tomography, and esophagogastroduodenoscopy with Helicobacter pylori testing were normal. A biopsy specimen from the descending duodenum showed no signs of inflammation, celiac disease, Whipple disease, or lambliasis. A colonoscopy revealed mucosal edema and a diminished vascular pattern [1] ([Fig. 1]). Biopsy specimens obtained from the sigmoid colon showed features of collagenous colitis ([Fig. 2]), which led to the diagnosis of microscopic (collagenous) colitis. The patient was treated with budenoside [2], and her symptoms rapidly decreased. After 4 weeks, the microscopic findings were normal. Diarrhea is common in patients with solid organ transplants and is usually attributed to infection or side effects of medication. The suspicion of microscopic colitis in a patient with a transplant is counterintuitive because immunosuppressants are effective in the treatment of microscopic colitis. Only a few cases have been reported, none of them in patients with heart transplants [3]. We cannot completely rule out gastrointestinal infection, as has been reported for lymphocytic colitis [4]. However, infection-associated collagenous colitis is unlikely. Of the possibly causative drugs, the patient´s medications included a proton pump inhibitor and a statin, but no nonsteroidal anti-inflammatory drug [5]. The patient’s medication was not changed during follow-up. To the best of our knowledge, this is the first report of microscopic colitis occurring in a patient with a heart transplant. Microscopic colitis should be considered when diarrhea of unknown etiology occurs in a patient with a solid organ transplant. Endoscopy_UCTN_Code_CCL_1AD_2AD
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study
- 15 April 2012
- Published by Springer Nature in Der Gastroenterologe
- Vol. 7 (3) , 245-246
Interferonfreie orale Therapie der Hepatitis C
- 15 April 2012
- Published by Springer Nature in Der Gastroenterologe
- Vol. 7 (3) , 245-246
Interferonfreie orale Therapie der Hepatitis C
- Open Access
- 1 March 2012
- Published by Brieflands in Hepatitis Monthly
- Vol. 12 (3) , 209-210
HFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis
HFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis - Hepatitis Monthly - 2012 - Kowsar
- 1 March 2012
- Published by Brieflands in Hepatitis Monthly
- Vol. 12 (3) , 209-210
Open AccessHFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis
HFE Gene Mutations, Iron Overload and Cryptogenic Liver Cirrhosis - Hepatitis Monthly - 2012 - Kowsar